For over 60 years, Metformin has been the standard treatment for managing blood sugar levels in patients with type 2 diabetes. Traditionally, it has been understood that Metformin primarily lowers blood glucose by reducing glucose output in the liver.
However, recent research conducted by scientists at Baylor College of Medicine and international collaborators has unveiled a significant new pathway through which Metformin operates, particularly affecting the brain.
On March 25, 2026, the findings were published in Science Advances, highlighting that Metformin works by turning off the protein Rap1 in the ventromedial hypothalamus (VMH), a critical brain region involved in regulating energy balance and glucose metabolism.
Dr. Makoto Fukuda, a lead researcher, stated, “This discovery changes how we think about Metformin.” The study revealed that mice lacking Rap1 did not show improvement in diabetes-like conditions when treated with Metformin, emphasizing the importance of this protein in the drug’s efficacy.
Furthermore, the research indicated that Metformin activates SF1 neurons in the VMH, suggesting their involvement in the drug’s action. Notably, the brain responds to much lower concentrations of Metformin compared to the liver and gut, which require higher doses to elicit a response.
In addition to its primary use for diabetes, Metformin has been associated with other health benefits, including slowing brain aging. A study found that women taking Metformin had a 30% lower risk of dying before age 90 compared to those on sulfonylurea, further highlighting its potential as a gerotherapeutic.
The implications of these findings are significant, as they open the door to developing new diabetes treatments that directly target this newly identified brain pathway. Dr. Fukuda noted, “These findings open the door to developing new diabetes treatments that directly target this pathway in the brain.”
As research continues, understanding how Metformin affects brain function could lead to innovative approaches in diabetes care and management.
